KBI Dongkook Ind Co Ltd
KRX:001620
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
K
|
KBI Dongkook Ind Co Ltd
KRX:001620
|
KR |
|
BeOne Medicines AG
SSE:688235
|
CH |
|
A
|
Aflac Inc
SWB:AFL
|
US |
|
O
|
Oculis Holding AG
SWB:CR5
|
CH |
|
L
|
Link Real Estate Investment Trust
F:L5R
|
HK |
|
Morien Resources Corp
XTSX:MOX
|
CA |
|
E
|
Experian PLC
OTC:EXPGY
|
IE |
|
Tokyo Electron Ltd
TSE:8035
|
JP |
|
BioNeutra Global Corp
XTSX:BGA
|
CA |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is KBI Dongkook Ind Co Ltd's stock price target?
Not Available
KBI Dongkook Ind Co Ltd does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for KBI Dongkook Ind Co Ltd?
Projected CAGR
-1%
Over the last 13 years, the compound annual growth rate for Revenue has been 6%. The projected CAGR for the next 11 years is -1%.
What is the Gross Profit forecast for KBI Dongkook Ind Co Ltd?
Projected CAGR
-4%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 8%. The projected CAGR for the next 11 years is -4%.
What is the Operating Income forecast for KBI Dongkook Ind Co Ltd?
Projected CAGR
-1%
Over the last 13 years, the compound annual growth rate for Operating Income has been -1%. The projected CAGR for the next 11 years is -1%.
What is the Pre-Tax Income forecast for KBI Dongkook Ind Co Ltd?
Projected CAGR
-6%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 6%. The projected CAGR for the next 11 years is -6%.
What is the Net Income forecast for KBI Dongkook Ind Co Ltd?
Projected CAGR
-7%
Over the last 13 years, the compound annual growth rate for Net Income has been 8%. The projected CAGR for the next 11 years is -7%.